RBI
ALNY icon

Raiffeisen Bank International’s Alnylam Pharmaceuticals ALNY Stock Holding History

Raiffeisen Bank International’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Buy
13,510
+3,097
+30% +$934K 0.05% 217
2026
Q1 		$3.29M Sell
10,413
-1,093
-9% -$372K 0.05% 218
2025
Q4 		$4.57M Sell
11,506
-103
-0.9% -$45.6K 0.06% 189
2025
Q3 		$5.19M Buy
11,609
+2,705
+30% +$1.1M 0.07% 174
2025
Q2 		$2.87M Buy
+8,904
New +$2.46M 0.04% 198

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raiffeisen Bank International's ALNY Position: Q2 2026 in Review

Raiffeisen Bank International increased its Alnylam Pharmaceuticals (ALNY) stake by 30% in Q2 2026, buying an estimated $934K and bringing the position to 13,510 shares worth $3.97M. The position accounts for 0.05% of the portfolio, ranked #217.

Raiffeisen Bank International first reported a position in ALNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.19M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Raiffeisen Bank International held 13,510 shares of Alnylam Pharmaceuticals worth $3.97M as of Q2 2026.
  • Raiffeisen Bank International bought 3,097 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $934K.
  • Alnylam Pharmaceuticals made up 0.05% of Raiffeisen Bank International's portfolio in Q2 2026, its #217 holding.
  • Raiffeisen Bank International first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Raiffeisen Bank International's Alnylam Pharmaceuticals position peaked at $5.19M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.